Generation of T-cell receptor retrogenic mice

被引:210
作者
Holst, Jeff [1 ]
Szymczak-Workman, Andrea L. [1 ]
Vignali, Kate M. [1 ]
Burton, Amanda R. [1 ]
Workman, Creg J. [1 ]
Vignali, Dario A. A. [1 ]
机构
[1] St Jude Childrens Hosp, Dept Immunol, Memphis, TN 38105 USA
关键词
D O I
10.1038/nprot.2006.61
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
T-cell receptor (TCR) transgenic (Tg) mice have revolutionized our understanding of many aspects of T-cell biology. Whereas they provide an almost unlimited source of T cells with a single specificity, breeding them onto different backgrounds and/or new knockout/knock-in mouse models is often time-consuming ( 6 months to several years), which can make the process costly and can significantly delay research. This protocol describes a new method for expressing defined TCR-alpha and TCR-beta proteins from a single 2A peptide-linked multicistronic retroviral vector in mice, using retrovirus-mediated stem cell gene transfer. We refer to these as 'retrogenic' (Rg) mice ('retro' from retrovirus and 'genic' from Tg) to avoid confusion with traditional transgenic mice. We have successfully used this approach to express over 50 different TCRs on several different mouse backgrounds in as little as 6 weeks.
引用
收藏
页码:406 / 417
页数:12
相关论文
共 22 条
[11]   Rapid analysis of T-cell selection in vivo using T cell-receptor retrogenic mice [J].
Holst, J ;
Vignali, KM ;
Burton, AR ;
Vignali, DAA .
NATURE METHODS, 2006, 3 (03) :191-197
[12]   T-CELL TOLERANCE AND AUTOIMMUNITY IN TRANSGENIC MODELS OF CENTRAL AND PERIPHERAL TOLERANCE [J].
MILLER, JFAP ;
FLAVELL, RA .
CURRENT OPINION IN IMMUNOLOGY, 1994, 6 (06) :892-899
[13]   An improved method for generating retroviral producer clones for vectors lacking a selectable marker gene [J].
Persons, DA ;
Mehaffey, MG ;
Kaleko, M ;
Nienhuis, AW ;
Vanin, EF .
BLOOD CELLS MOLECULES AND DISEASES, 1998, 24 (09) :167-182
[14]   Retroviral-mediated transfer of the green fluorescent protein gene into murine hematopoietic cells facilitates scoring and selection of transduced progenitors in vitro and identification of genetically modified cells in vivo [J].
Persons, DA ;
Allay, JA ;
Allay, ER ;
Smeyne, RJ ;
Ashmun, RA ;
Sorrentino, BP ;
Nienhuis, AW .
BLOOD, 1997, 90 (05) :1777-1786
[15]   Use of the green fluorescent protein as a marker to identify and track genetically modified hematopoietic cells [J].
Persons, DA ;
Allay, JA ;
Riberdy, JM ;
Wersto, RP ;
Donahue, RE ;
Sorrentino, BP ;
Nienhuis, AW .
NATURE MEDICINE, 1998, 4 (10) :1201-1205
[16]   BETAINE CAN ELIMINATE THE BASE PAIR COMPOSITION DEPENDENCE OF DNA MELTING [J].
REES, WA ;
YAGER, TD ;
KORTE, J ;
VONHIPPEL, PH .
BIOCHEMISTRY, 1993, 32 (01) :137-144
[17]   FOOT-AND-MOUTH-DISEASE VIRUS 2A OLIGOPEPTIDE MEDIATED CLEAVAGE OF AN ARTIFICIAL POLYPROTEIN [J].
RYAN, MD ;
DREW, J .
EMBO JOURNAL, 1994, 13 (04) :928-933
[18]   The CD3ε proline-rich sequence, and its interaction with Nck, is not required for T cell development and function [J].
Szymczak, AL ;
Workman, CJ ;
Gil, D ;
Dilioglou, S ;
Vignali, KM ;
Palmer, E ;
Vignali, DAA .
JOURNAL OF IMMUNOLOGY, 2005, 175 (01) :270-275
[19]   Development of 2A peptide-based strategies in the design of multicistronic vectors [J].
Szymczak, AL ;
Vignali, DAA .
EXPERT OPINION ON BIOLOGICAL THERAPY, 2005, 5 (05) :627-638
[20]   Correction of multi-gene deficiency in vivo using a single 'self-cleaving' 2A peptide-based retroviral vector [J].
Szymczak, AL ;
Workman, CJ ;
Wang, Y ;
Vignali, KM ;
Dilioglou, S ;
Vanin, EF ;
Vignali, DAA .
NATURE BIOTECHNOLOGY, 2004, 22 (05) :589-594